BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 37901913)

  • 1. Investigation of the quarter-dose 18 F-FDG total-body PET in routine clinical practice and its clinical value.
    Zhao M; Zan K; Cui X; Chai L; Ge M; Cheng Z; Sun H; Duan Y
    Nucl Med Commun; 2023 Dec; 44(12):1176-1183. PubMed ID: 37901913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Half-dose versus full-dose 18 F-FDG total-body PET/CT in patients with colorectal cancer.
    Tan H; Mao W; Cao Y; Cai D; Sui X; Qi C; Yu H; Zhang Y; Shi H
    Nucl Med Commun; 2022 Aug; 43(8):928-936. PubMed ID: 35634804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total-body
    Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience.
    Tan H; Cai D; Sui X; Qi C; Mao W; Zhang Y; Liu G; Yu H; Chen S; Hu P; Gu J; Shi H
    Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1002-1011. PubMed ID: 34462790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-head intra-individual comparison of total-body 2-[
    Chen X; Hu P; Yu H; Tan H; He Y; Cao S; Zhou Y; Shi H
    Eur Radiol; 2023 Nov; 33(11):7890-7898. PubMed ID: 37338551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
    Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultralow-dose [
    Tan H; Qi C; Cao Y; Cai D; Mao W; Yu H; Sui X; Liu G; Shi H
    Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low
    Hu Y; Liu G; Yu H; Wang Y; Li C; Tan H; Chen S; Gu J; Shi H
    J Nucl Med; 2022 Jun; 63(6):959-965. PubMed ID: 34593593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of image quality between step-and-shoot and continuous bed motion techniques in whole-body
    Yamashita S; Yamamoto H; Nakaichi T; Yoneyama T; Yokoyama K
    Ann Nucl Med; 2017 Nov; 31(9):686-695. PubMed ID: 28815414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time.
    Brown C; Dempsey MF; Gillen G; Elliott AT
    Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing acquisition times for total-body positron emission tomography/computed tomography with half-dose
    He Y; Gu Y; Yu H; Wu B; Wang S; Tan H; Cao Y; Chen S; Sui X; Zhang Y; Shi H
    EJNMMI Phys; 2022 Jul; 9(1):45. PubMed ID: 35802280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image quality and lesion detectability in low-dose pediatric
    Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the long axial field-of-view PET/CT with low-dose [
    Sachpekidis C; Pan L; Kopp-Schneider A; Weru V; Hassel JC; Dimitrakopoulou-Strauss A
    Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1158-1167. PubMed ID: 36474125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical feasibility and impact of fully automated multiparametric PET imaging using direct Patlak reconstruction: evaluation of 103 dynamic whole-body
    Dias AH; Pedersen MF; Danielsen H; Munk OL; Gormsen LC
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):837-850. PubMed ID: 32894338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New standards for phantom image quality and SUV harmonization range for multicenter oncology PET studies.
    Akamatsu G; Shimada N; Matsumoto K; Daisaki H; Suzuki K; Watabe H; Oda K; Senda M; Terauchi T; Tateishi U
    Ann Nucl Med; 2022 Feb; 36(2):144-161. PubMed ID: 35029817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of patient's habitus on image quality and quantitative metrics in 18F-FDG PET/CT images.
    Zorz A; D'Alessio A; Guida F; Ramadan RM; Richetta E; Cuppari L; Pellerito R; Sacchetti GM; Brambilla M; Paiusco M; Stasi M; Matheoud R
    Phys Med; 2023 May; 109():102584. PubMed ID: 37060633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phantom-based acquisition time and image reconstruction parameter optimisation for oncologic FDG PET/CT examinations using a digital system.
    Fragoso Costa P; Jentzen W; Brahmer A; Mavroeidi IA; Zarrad F; Umutlu L; Fendler WP; Rischpler C; Herrmann K; Conti M; Seifert R; Sraieb M; Weber M; Kersting D
    BMC Cancer; 2022 Aug; 22(1):899. PubMed ID: 35978274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
    Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
    Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
    Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The image quality, lesion detectability, and acquisition time of
    Zhang YQ; Hu PC; Wu RZ; Gu YS; Chen SG; Yu HJ; Wang XQ; Song J; Shi HC
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2507-2515. PubMed ID: 32424483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.